Author(s): Nur Samsu, Setyawati Soeharto, Muhaimin Rifai, Achmad Rudijanto

Email(s): drnursamsu@gmail.com , watikaryono@gmail.com , rifai123@ub.ac.id , achmadrudijanto@yahoo.co.id

DOI: 10.5958/2231-5691.2020.00025.8   

Address: Nur Samsu1, Setyawati Soeharto2, Muhaimin Rifai3, Achmad Rudijanto4
1Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
2Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
3Department of Biology, Faculty of Mathematics and Sciences, Universitas Brawijaya, Malang, Indonesia.
4Department of Internal Medicine, Division of Endocrinology and Metabolic, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
*Corresponding Author

Published In:   Volume - 10,      Issue - 3,     Year - 2020


ABSTRACT:
Background: Oxidative stress plays an important role in podocyte injury and hence in the development and progression of diabetic nephropathy (DN). The present study was to compare the effect of antioxidant rosmarinic acid (RA) and vitamin E (VtE) in preventing development and inhibiting progression of DN in rats. Methods: Sixteen male Wistar rats were divided into 4 groups each of 4. The 1st group acts as normal rats. The 2nd group acts as untreated-diabetic rats. The 3rd group acts as treated diabetic rats with RA at doses 75 mg/kg/day, and the 4th group acts as treated diabetic rats with VtE at dose 400 mg/kg/day and treatment continued for 8 weeks. Urinary level of podocin, nephrin, albumin, and serum cystatin C levels were measured at the end of the study by ELISA. Immunohistochemistry were used to examined the expression of p65 NF-kB whereas the expression of podocin and nephrin glomerulus were examined by immunofluorescence. Results: The excretion of nephrin, podocin and albumin urine, expression of p65 NF-kB, and level of cystatin C serum were significantly lower in the RA group compared with the VtE group, whereas expression of glomerular nephrin and podocin in the RA group were higher compared with the VtE group. Compared to the untreated-diabetic rats, the expression of glomerular nephrin and podocin, and cystatin C serum level in the VtE group did not differed significantly. Conclusions: In streptozotocin-induced diabetic rats, RA superior than VtE in preventing development and inhibiting progression of diabetic nephropathy.


Cite this article:
Nur Samsu, Setyawati Soeharto, Muhaimin Rifai, Achmad Rudijanto. The Superiority of Rosmarinic Acid over Vitamin E in Preventing Development and Inhibiting Progression of Diabetic Nephropathy in Rats. Asian J. Pharm. Res. 2020; 10(3):131-139. doi: 10.5958/2231-5691.2020.00025.8


REFERENCES:
1. Al-Waili N, Al-Waili H, Al-Waili T, and Salom K. Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials. REDOX REPORT. 2017, 22 (3): 99–118.
2. Muller-Deile J, Schiffer M. The podocyte power-plant disaster and its contribution to glomerulopathy. Frontier in endocrinology. 2014, 5 (209): 1- 6.
3. Vega-Warner V, Ransom RF, Vincent AM, et al. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int. 2004, 66:1881-1889.
4. Shankland SJ. The Podocyte’s Response to Injury: Role in Proteinuria and Glomerulus. Kidney Int. 2006, 09:2131 – 2147.
5. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005, 67: 404-419.
6. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013, 2:20-27.
7. Liu P, Feng Y, Wang Y, Zhou Y, and Zhao L. Protective effect of vitamin E against acute kidney injury. Biomed. Mater. Eng. 2015, 26: S2133–S2144.
8. Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med. 1991, 10(5):263-75.
9. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 2003, 14 (8 Suppl. 3): S250–S253.
10. Haidara MA, Mikhailidis DP, Rateb MA., et al. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin induced Type 1 diabetes. J. Diabetes Complications. 2009, 23: 130–136.
11. Hayashi D, Yagi K, Song C et al. Diacylglycerol kinase alpha is involved in the vitamin E-induced amelioration of diabetic nephropathy in mice. Sci. Rep. 2017,7:2597.
12. Jeanette S, Alex K, and Adviye E. Oxidative stress and the use of antioxidants in diabetes. Cardiovasc Diabetol. 2005, 4:5–9.
13. Tursun A, Astumi N, Hiroyuki M, et al. A natural scavenger of peroxynitrites, protects against impairment of memory induced by Ab25–35. Behav Brain Res.2007;180:139–145.
14. Mushtaq N, Schmatz R, Ahmed M, et al. Protective effect of rosmarinic acid against oxidative stress biomarkers in liver and kidney of strepotozotocin-induced diabetic rats. J Physiol Biochem.2015, 71(4):743–751.
15. Jiang WL, Xu Y, Zhang SP, Hou J, Zhu HB. Effect of Rosmarinic Acid on Experimental Diabetic Nephropathy. Basic & clinical pharmacology & toxicology. 2012, 110 (4): 390–395
16. Moskaug JO, Carlsen H, Myhrstad MC, Blomhoff R. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr. 2005, 81(1):277S–283S.
17. Samsu N, Soeharto S, Rifai M, et al. Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats. Biologics: Targets and Therapy 2019:13 179–190
18. Furman BL. Streptozotocin-induced diabetic models in mice and rats. Current protocol in pharmacology. 2015, 7(1): 5.47.1 – 5.47.20.
19. Rangan G and Tesch GH. Quantification of renal pathology by image analysis (Methods in Renal Research). NEPHROLOGY. 2007, 12: 553–558.
20. Zhao Y, Zhang W, Jia Q, et al. High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress. Front. Physiol. 2019, 9:1939.
21. Hirnerová E, Krahulec B, Strbová L, et al. Effect of vitamin E therapy on progression of diabetic nephropathy. Vnitr Lek. 2003, 49(7):529–534.
22. Hirnerova E, Krahulec B, Strbova L, et al. Effect of vitamin E supplementation on microalbuminuria, lipid peroxidation and blood prostaglandins in diabetic patients. Bratisl Lek Listy. 2004, 105:408–413.
23. Farvid MS, Jalali M, Siassi F, Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type2 diabetes. Diabetes care. 2005;28(10):2458–2464.
24. Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type2 diabetic patients. Diabetic medicine: a journal of the British Diabetic Association. 2001, 18(9):756–760.
25. Reddy GR, Kotlyarevska K, Ransom RF, Menon RK. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens. 2008, 17(1):32-36.
26. Greiber S, Muller B, Daemisch P, Pavenstadt H. Reactive oxygen species alter gene expression in podocytes: Induction of granulocyte macrophage‐colony‐stimulating factor. J. Am. Soc. Nephrol. 2002, 13: 86– 95.
27. Nam J, Cho M, Lee G. The activation of NF-κB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res Clin Prac. 2008, 81:25–32.
28. Baynes W and Thorpe S. The role of oxidative stress in diabetic complications. Cur Opininion Endocrinol Diabetes. 1996, 3:277 – 284.
29. Hussain S, Romio L, Saleem M et al. Nephrin Deficiency Activates NF-κB and Promotes Glomerular Injury. J Am Soc Nephrol. 2009, 20 (8): 1733–1743.
30. Kumar PA, Welsh GI, Raghu G et al. Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus. Arch Biochem Biophys. 2006, 590: 10–19.
31. Otero P, Bonet B, Herrera E, Rabano A. Development of atherosclerosis in the diabetic BALB/c mice prevention with vitamin E administration. Atheroscler. 2005, 182:259–65.
32. Shirpoor A, Iikhanizadeh B, Saadatian R, et al. Effect of Vitamin E on diabetes-induced changes in small intestine and plasma antioxidant capacity in rats. J Physiol Biochem 2006, 62: 171-177.
33. Jayanthy G and Subramanian S. Rosmarinic acid, a polyphenol, ameliorates hyperglycemia by regulating the key enzymes of carbohydrate metabolism in high fat diet – STZ induced experimental diabetes mellitus. Biomedicine & Preventive Nutrition, 2014:431-437.
34. Li B, Cui W, Tan Y, et al. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J Cell Mol Med. 2014, 18 (5):895–906.
35. Comper WD, Osicka TM, and Jerums G. “High prevalence of immuno-unreactive intact albumin in urine of diabetic patients,” AJKD, 2003, 41 (1): 336–342.
36. Rao X, Wan M, Qiu Q, and Jiang C. “Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus,” Experimental and Therapeutic Medicine, 2014: 8 (3): 887–892.
37. Schuck O, Teplan V, Sibova J, Stollova M. Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment. Int J Clin Pharmacol Ther. 2004; 42:93-7

Recomonded Articles:

Author(s): AK Meena, MM Rao, RP Meena, P Panda, Renu

DOI:         Access: Open Access Read More

Author(s): R. R. Shah, S. A. Mohite, N. R. Patel

DOI: 10.5958/2231-5691.2018.00007.2         Access: Open Access Read More

Author(s): Neha Meshram, Mithlesh Ojha, Ajay Singh, Amit Alexander, Ajazuddin, Mukesh Sharma

DOI: 10.5958/2231-5691.2015.00009.X         Access: Open Access Read More

Author(s): P. Muthukumaran, P. Shanmuganathan , C. Malathi

DOI:         Access: Open Access Read More

Author(s): Nitin Mahurkar, Sayeed ul hasan S.M

DOI:         Access: Open Access Read More

Author(s): Abhijit Ray

DOI:         Access: Open Access Read More

Author(s): Rangarajan Narasimhan, Sathiyamoorthy. M

DOI: 10.5958/2231-5691.2016.00001.0         Access: Open Access Read More

Author(s): Batra Neha, Jain Honey, Bairwa Ranjan, Bachwani Mukesh

DOI:         Access: Open Access Read More

Author(s): Valli G, Jeyalakshmi M.

DOI:         Access: Open Access Read More

Author(s): Jadhav Sameer S., Salunkhe Vijay R. , Magdum Chandrakant S.

DOI:         Access: Open Access Read More

Author(s): Gadilohar N. R, Girase A. M, Suryawanshi H. P, Pawar S. P

DOI: 10.5958/2231-5691.2018.00030.8         Access: Open Access Read More

Author(s): Srivastav Sanchit, Luhach Kanishk, Shukla Chhama, Yadav Rajender

DOI:         Access: Open Access Read More

Author(s): Yusa Herwanto, Syafruddin Ilyas, Juliandi Harahap

DOI: 10.5958/2231-5691.2019.00004.2         Access: Closed Access Read More

Author(s): Betsy Joseph, Anuradha V. P, Jayakrishnan S. S, Ajith B

DOI: 10.5958/2231-5691.2019.00027.3         Access: Closed Access Read More

Author(s): Shivani Sharma, Manpreet Rana, Hitesh Kumar , Bharat Parashar

DOI:         Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 


Recent Articles




Tags